SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-020459
Filing Date
2022-04-19
Accepted
2022-04-19 06:01:43
Documents
4
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0422_inmunebio.htm DEF 14A 922503
2 GRAPHIC tinmunebio_logo.jpg GRAPHIC 89408
3 GRAPHIC tproxy_001.jpg GRAPHIC 939211
4 GRAPHIC tproxy_002.jpg GRAPHIC 790898
  Complete submission text file 0001213900-22-020459.txt   3430311
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38793 | Film No.: 22833378
SIC: 2836 Biological Products, (No Diagnostic Substances)